These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2770785)

  • 1. Nondystrophic myoblast transplantation into dystrophic muscle.
    Karpati G
    Muscle Nerve; 1989 Apr; 12(4):337-9. PubMed ID: 2770785
    [No Abstract]   [Full Text] [Related]  

  • 2. Histoincompatible myoblast injection improves muscle structure and function of dystrophic mice.
    Law PK; Goodwin TG; Li HJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1114-9. PubMed ID: 3388493
    [No Abstract]   [Full Text] [Related]  

  • 3. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation.
    Kinoshita I; Huard J; Tremblay JP
    Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles.
    Vilquin JT; Guérette B; Puymirat J; Yaffe D; Tomé FM; Fardeau M; Fiszman M; Schwartz K; Tremblay JP
    Gene Ther; 1999 May; 6(5):792-800. PubMed ID: 10505103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional improvement of skeletal muscles of dystrophic mice following electrical stimulation [proceedings].
    Luthert P; Vrbová G; Ward KM
    J Physiol; 1979 Jun; 291():31P. PubMed ID: 314512
    [No Abstract]   [Full Text] [Related]  

  • 6. Normal myoblast implantation in MDX mice prevents muscle damage by exercise.
    Brussee V; Merly F; Tardif F; Tremblay JP
    Biochem Biophys Res Commun; 1998 Sep; 250(2):321-7. PubMed ID: 9753628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymerase chain reaction-based assay to assess the success of myoblast transplantation in mdx mice.
    Asselin I; Tremblay M; Vilquin JT; Guérette B; Tremblay JP
    Transplant Proc; 1994 Dec; 26(6):3389. PubMed ID: 7527970
    [No Abstract]   [Full Text] [Related]  

  • 8. Muscle transplantation in normal and dystrophic animals.
    Dubowitz V; Neerunjun J
    J Physiol; 1973 Jun; 231(2):61P. PubMed ID: 4146463
    [No Abstract]   [Full Text] [Related]  

  • 9. Morphological studies on transplanted muscle between normal and dystrophic animals.
    Dubowitz V
    J Physiol; 1973 Jun; 231(2):59P. PubMed ID: 4269055
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention by anti-LFA-1 of acute myoblast death following transplantation.
    Guérette B; Skuk D; Célestin F; Huard C; Tardif F; Asselin I; Roy B; Goulet M; Roy R; Entman M; Tremblay JP
    J Immunol; 1997 Sep; 159(5):2522-31. PubMed ID: 9278346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal myoblast injections provide genetic treatment for murine dystrophy.
    Law PK; Goodwin TG; Wang MG
    Muscle Nerve; 1988 Jun; 11(6):525-33. PubMed ID: 3386660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
    Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
    Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multivariate study on enzymatic changes in limb muscles and heart muscle of dystrophic mice.
    Aoyagi T; Wada T; Kojima F; Nagai M; Harada S; Umezawa H
    Biotechnol Appl Biochem; 1987 Oct; 9(5):355-61. PubMed ID: 3675874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous regeneration of older dystrophic muscle does not reflect its regenerative capacity.
    Bourke DL; Ontell M; Taylor F
    Am J Anat; 1988 Jan; 181(1):1-11. PubMed ID: 3348143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.
    Ohtsuka Y; Udaka K; Yamashiro Y; Yagita H; Okumura K
    J Immunol; 1998 May; 160(9):4635-40. PubMed ID: 9574572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.
    Alter J; Lou F; Rabinowitz A; Yin H; Rosenfeld J; Wilton SD; Partridge TA; Lu QL
    Nat Med; 2006 Feb; 12(2):175-7. PubMed ID: 16444267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of altered metabolism (hypothyroidism) on muscle repair in the mdx dystrophic mouse.
    McIntosh LM; Pernitsky AN; Anderson JE
    Muscle Nerve; 1994 Apr; 17(4):444-53. PubMed ID: 8170492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased parvalbumin contents in skeletal muscles of C57BL/6J(dy2J/dy2J) dystrophic mice.
    Klug G; Reichmann H; Pette D
    Muscle Nerve; 1985 Sep; 8(7):576-9. PubMed ID: 4047089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regeneration of dystrophic muscle following multiple injections of bupivacaine.
    Martin H; Ontell M
    Muscle Nerve; 1988 Jun; 11(6):588-96. PubMed ID: 3386667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Muscle protein turnover in the dystrophic mice].
    Mizobuchi M
    Rinsho Shinkeigaku; 1983 May; 23(5):436-44. PubMed ID: 6883888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.